Tyberg Amy, Sarkar Avik, Shahid Haroon M, Shah-Khan Sardar M, Gaidhane Monica, Simon Alexa, Eisenberg Ian A, Lajin Michael, Karagyozov Petko, Liao Kelvin, Patel Roohi, Zhao Eric, Martínez Ma Guadalupe, Artifon Everson L, Lino André D, Vanella Giuseppe, Arcidiacono Paolo G, Kahaleh Michel
Gastroenterology, Robert Wood Johnson Medical School, New Brunswick, NJ.
GI associate Milwaukee, Milwaukee, KY.
J Clin Gastroenterol. 2023 Oct 1;57(9):962-966. doi: 10.1097/MCG.0000000000001795.
Endoscopic ultrasound-guided biliary drainage (EUS-BD) is the procedure of choice for patients who cannot undergo endoscopic retrograde cholangiopancreatography (ERCP). The outcomes of patients undergoing surgery after EUS-BD for malignancy are unknown.
We conducted an international, multicenter retrospective comparative study of patients who underwent hepatobiliary surgery after having undergone EUS-BD or ERCP from 6 tertiary care centers. Patient demographics, procedural data, and follow-up care were collected in a registry.
One hundred forty-five patients were included: EUS-BD n=58 (mean age 66, 45% male), ERCP n=87 (mean age 68, 53% male). The majority of patients had pancreatic cancer, cholangiocarcinoma, or gallbladder malignancy. In the EUS-BD group, 29 patients had hepaticogastrostomy, 24 had choledochoduodenostomy, and 5 had rendezvous technique done. The most common surgery was Whipple in both groups (n=41 EUS-BD, n=56 ERCP) followed by partial hepatectomy (n=7 EUS-BD, n=14 ERCP) and cholecystectomy (n=2 EUS-BD, n=2 ERCP). Endoscopy clinical success was comparable in both groups (98% EUS-BD, 94% ERCP). Adverse event rates were similar in both groups: EUS-BD (n=10, 17%) and ERCP (n=23, 26%). Surgery technical success and clinical success were significantly higher in the EUS-BD group compared with the ERCP group (97% vs. 83%, 97% vs. 75%). Total Hospital stay from surgery to discharge was significantly higher in the ERCP group (19 d vs. 10 d, P =0.0082).
Undergoing EUS-BD versus ERCP before hepatobiliary surgery is associated with fewer repeat endoscopic interventions, shorter duration between endoscopy and surgical intervention, higher rates of surgical clinical success, and shorter length of hospital stay after surgery.
内镜超声引导下胆道引流术(EUS-BD)是无法接受内镜逆行胰胆管造影术(ERCP)患者的首选治疗方法。EUS-BD术后接受手术治疗的恶性肿瘤患者的预后尚不清楚。
我们对来自6家三级医疗中心的接受过EUS-BD或ERCP后接受肝胆手术的患者进行了一项国际多中心回顾性比较研究。在一个登记处收集患者人口统计学、手术数据和后续护理信息。
共纳入145例患者:EUS-BD组58例(平均年龄66岁,男性占45%),ERCP组87例(平均年龄68岁,男性占53%)。大多数患者患有胰腺癌、胆管癌或胆囊恶性肿瘤。在EUS-BD组中,29例患者行肝胃吻合术,24例行胆总管十二指肠吻合术,5例行会师技术。两组最常见的手术都是胰十二指肠切除术(EUS-BD组41例,ERCP组56例),其次是肝部分切除术(EUS-BD组7例,ERCP组14例)和胆囊切除术(EUS-BD组2例,ERCP组2例)。两组内镜检查临床成功率相当(EUS-BD组98%,ERCP组94%)。两组不良事件发生率相似:EUS-BD组(10例,17%)和ERCP组(23例,26%)。EUS-BD组手术技术成功率和临床成功率显著高于ERCP组(分别为97%对83%,97%对75%)。ERCP组从手术到出院的总住院时间显著更长(19天对10天,P=0.0082)。
在肝胆手术前接受EUS-BD与接受ERCP相比,重复内镜干预更少,内镜检查与手术干预之间的时间更短,手术临床成功率更高,术后住院时间更短。